Home Biosimilar Antibodies GPCR & G Protein Others Erenumab (Anti-CALCRL / CGRPR)
For research use only. Not for use in humans.

Erenumab (Anti-CALCRL / CGRPR)

Synonyms: null

Erenumab (Anti-CALCRL/CGRPR) is a fully human monoclonal antibody targeting CGRP receptor (calcitonin gene–related peptide receptor). Erenumab can be used for the prevention of episodic migraine. MW:145.5 KD.

Erenumab (Anti-CALCRL / CGRPR)

Quality Control

Batch: Purity: 99% Protein concentration: 7.43mg/ml Endotoxin Level: ＜1EU/mg
99

Mechanism of Action

Description
Erenumab (Anti-CALCRL/CGRPR) is a fully human monoclonal antibody targeting CGRP receptor (calcitonin gene–related peptide receptor). Erenumab can be used for the prevention of episodic migraine. MW:145.5 KD.

Product Details

CAS No. 1582205-90-0
Molecular Weight 145.5 kDa
Isotype Human IgG2SA
Source CHO
Purification AKTA
Sterility 0.2 μM filtered
Formulation 100 mM Pro-Ac, 20mM Arg, pH5.0
Storage
(From the date of receipt)		 Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Comparison of Clones for

*Literature analysis of various clone (for this target) products available on the market shows that Selleck's selected clones are more frequently applied. (data until September 2024)

Tech Support

Handling Instructions

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.